Navigation Links
CEO of BioConvergence® Receives Women Excel Bloomington Award for Outstanding Leadership and Service
Date:7/18/2013

Bloomington, Indiana (PRWEB) July 18, 2013

The Greater Bloomington Chamber of Commerce recently honored Alisa Wright, Founder and CEO of BioConvergence, a Bloomington-based contract manufacturing organization, with the Women Excel Bloomington (WEB) Award on July 9, 2013. The selection committee received a number of nominations and based final selection on “outstanding leadership and spirit in both the community and/or in their organization,” according to the Chamber’s related press release.

Wright’s industry experience began with Eli Lilly and Company, Cook Pharmaceutical Solutions, and Baxter Pharmaceutical Solutions and includes contributions to developing the first drug for pancreatic cancer, launching 50 clinical programs, and producing bio-defense vaccines and therapeutics for the U.S. government (including the first initiative following September 11, 2001), respectively.

After working for 25 years in large pharmaceutical and contract manufacturing organizations, she identified gaps in the industry and founded BioConvergence in an effort to help pharmaceutical and biotechnology companies streamline vendor management systems, mitigate risk, and move product to market, and to the patients in need... more quickly.

Throughout her career, Wright has actively participated in the community by offering her time to various lecturing and mentoring programs and serving on multiple advisory boards for surrounding academic institutions. She has also volunteered alongside organizations such as BioCrossroads and Indiana Health Industry Forum.

“Alisa’s broad expertise, acquired from a variety of diverse roles in the industry, has certainly played a significant role in her entrepreneurial achievements. But, her personal values, centered in hard work, authenticity, and the genuine desire to make the world a better place, define the patient-focused culture of BioConvergence that propels the organization’s success,” relates Lesli Stasiek, Global Manager of Business Development and Marketing.

Wright also attributes much of her success to her sources of inspiration: her parents. “My parents continue to be my mentors in life and business—balancing encouragement and correction as only those with the best intentions (and those who have a full knowledge of your strengths and weaknesses) can.”

Along with Wright, six other women were honored at the WEB Awards ceremony: Lisa Fulkerson, Vice President & CFO of Children’s Organ Transplant Association; Melanie Hart, President of TASUS Corporation; Beth Lodge-Rigal, Owner/Founder & Creative Director of Women Writing for Change Bloomington & Writing for Change; Natalia Rayzor, Employment Development Officer of IU Credit Union; Jean Willey Scallon, CEO & Managing Director of Bloomington Meadows Hospital; and Melinda Seader, Director of Marketing for World Wide Automotive.

About BioConvergence

BioConvergence is a contract manufacturing organization for the life sciences industry, offering outsourcing partnerships for formulation development, testing, production, and supply chain services. Headquartered in Bloomington, Indiana, they have over 50 employees with five centuries’ worth of combined experience in the pharmaceutical industry. Their unique E-Transparency® System provides transparency and flexibility to their clients, while offering superior, quality-driven outsourcing services. For more information, visit http://www.bioc.us.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10940705.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioConvergence® Celebrates Seventh Anniversary as a Life Sciences Contract Service Provider
2. BioConvergence® Launches New Blog Aimed at Exploring Best Practices of Pharmaceutical and Biotechnology Industries
3. BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment
4. UCSB professor receives award for graphene electronics research
5. Watsons Generic Yaz(R) Receives FDA Approval
6. Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin
7. Life Technologies Ion Personal Genome Machine Receives San Diegos CONNECT Most Innovative New Product Award
8. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
9. Intimate Bridge 2 Conception, Inc. Receives $4.3M
10. Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles
11. BioNeutral Group Receives $400,000 in Equity Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... HOUSTON , Feb. 9, 2016 /PRNewswire/ ... virus-driven immunotherapies for cancer, announced that its ... the European Commission as an orphan medicinal ... the deadliest form of glioma, strikes approximately ... and EU. http://photos.prnewswire.com/prnh/20160208/330986LOGO ...
(Date:2/9/2016)... , Feb. 9, 2016 ... Insights, 2016", report provides in depth insights ... activities around the Protein-Tyrosine Phosphatase 1B (PTP1B) ... profiles in various stages of development including ... Phase III and Preregistration. Report covers the ...
(Date:2/8/2016)... N.C. , Feb. 8, 2016 Novan, Inc. today ... Chairman of the Board of Directors of Novan. In addition, ... North Carolina . --> ... Company also announced that it received a total of $32.8 million ... 2015 from its private investor network originating throughout the Research Triangle ...
(Date:2/8/2016)... ... February 08, 2016 , ... Franz Inc. , an ... technology, today announced the availability of AllegroGraph 6, the leading Semantic Graph Database ... Certified Technology Program (CCPT). AllegroGraph is the first Semantic Graph Database to ...
Breaking Biology Technology:
(Date:1/28/2016)... JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: SYNA ... results for its second quarter ended December 31, 2015. ... second quarter of fiscal 2016 increased 2 percent compared to the ... second quarter of fiscal 2016 was $35.0 million, or $0.93 per ... Non-GAAP net income for the first quarter of fiscal 2016 grew ...
(Date:1/22/2016)... , January 22, 2016 /PRNewswire/ ... announced the addition of the  "Global ... their offering. --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) ...
(Date:1/20/2016)... 20, 2016   MedNet Solutions , an innovative ... of clinical research, is pleased to announce the attainment ... are the result of the company,s laser focus on ... , it,s comprehensive, easy-to-use and highly affordable cloud-based ... Key MedNet growth achievements in 2015 include: ...
Breaking Biology News(10 mins):